Prostate Cancer - Results from #680

REVIEW UroToday

A meta-analysis of long-term follow-up of high dose vs conventional dose in external beam radiotherapy of prostate cancer, "Beyond the Abstract," by Zan Hou, Guangjun Li, and Sen Bai March 12, 2015

Functional MRI in the detection of prostate cancer, "Beyond the Abstract," by Sandeep Sankineni, MD and Peter Choyke, MD March 10, 2015

Elucidating immunologic mechanisms of PROSTVAC cancer immunotherapy "Beyond the Abstract," by Stefanie Mandl, PhD March 4, 2015

A study assessing the risk of acute myocardial infarction in a Chinese population after androgen deprivation therapy for prostate cancer, "Beyond the Abstract," by Jeremy Y.C. Teoh, MBBS, MRCSEd and Anthony C.F. Ng, FRCSEd (Urol), FHKAM (Surgery) March 4, 2015

Frequency of diagnosis, morphologic subpatterns, and relation to pattern distribution of adenocarcinoma of the prostate with Gleason pattern 5 on core biopsy based on the modified Gleason grading system, "Beyond the Abstract," by Rajal B. Shah, MD February 26, 2015

Risk of new-onset diabetes in the Asian population after androgen deprivation therapy for prostate cancer, "Beyond the Abstract," by Jeremy Y.C. Teoh, MBBS, MRCSEd and Anthony C.F. Ng, FRCSEd (Urol), FHKAM (Surgery) February 24, 2015

Prognostic significance of time to PSA nadir and its relationship to survival beyond time to PSA nadir for prostate cancer patients with bone metastases after primary ADT, "Beyond the Abstract," by Jeremy Y.C. Teoh, MBBS, MRCSEd and Ming-Kwong Yiu, FRCSEd February 11, 2015

Tolerance of Phellodendron amurense bark extract (Nexrutine®) in patients with human prostate cancer, "Beyond the Abstract," by Gregory P. Swanson, MD February 10, 2015

Prognostic impact of time to undetectable prostate-specific antigen in patients with positive surgical margins following radical prostatectomy, "Beyond the Abstract," by Kyo Chul Koo and Koon Ho Rha February 5, 2015

Translating genetic risk factors for prostate cancer to the clinic, "Beyond the Abstract," by Christos Mikropoulos February 3, 2015

The use of a hydrogel spacer to reduce safety risks in postoperative salvage radiotherapy for prostate cancer, "Beyond the Abstract," by Michael Pinkawa, MD January 29, 2015

A SEER-based study for identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer, "Beyond the Abstract," by Nicola Fossati and Firas Abdollah January 29, 2015

A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Arun Azad, MBBS, PhD, FRACP January 28, 2015

Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer, "Beyond the Abstract," by Richard Wilder, MD, MS, MBA January 27, 2015

Secondary sarcoma of bone post-prostate brachytherapy: A case report, "Beyond the Abstract," by Jessica Conway, MD and Michael McKenzie, MD January 24, 2015

Review of the literature regarding metastatic prostate carcinoma to the skin, "Beyond the Abstract," by Gabrielle E. Brown, MS, et al January 22, 2015

National trends in the management of low- and intermediate-risk prostate cancer in the United States, "Beyond the Abstract," by Adam B. Weiner January 16, 2015

Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer, "Beyond the Abstract," by Melissa A. Babcook, PhD and Sanjay Gupta, PhD January 13, 2015

Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and Prostate Health Index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer, "Beyond the Abstract," by Nicola Fossati, et al January 10, 2015

Objective grading of prostate carcinoma based on fractal dimensions, "Beyond the Abstract," by P. Waliszewski, FEBU January 9, 2015

Page 35 of 57